Newsletter · · Ashutosh Agarwal
UnitedHealth's 2027 Reset Takes Shape With HMOs In and PPOs Out - Managed Care Under Pressure - Week of September 5, 2026
Managed care for the week of September 5, 2026: the 2027 benefit-design season opened with UnitedHealth dropping PPOs and going all-in on tightly managed HMOs, CMS handing carriers hard enrollment caps, a $542 million Humana overbilling settlement, and employers pushing GLP-1 costs off their books.
Managed Care Under Pressure
Week of September 5, 2026: UnitedHealth's 2027 Reset Takes Shape With HMOs In and PPOs Out
The 2027 playbook is finally leaking, and it says "shrink, reprice, protect the good members."
The 2027 benefit-design season kicked off this week and the podcasts filled in real detail on how the big Medicare Advantage carriers plan to reset next year. The headline: UnitedHealth is pulling out of PPO plans, going all-in on tightly managed HMO plans, and clawing back the members it lost a year ago. On top of that, regulators handed carriers a brand-new tool to slam the door on money-losing plans, and Humana got hit with a $542 million Medicare overbilling settlement. Most of the week's coverage came from insurance-agent, policy and drug-pricing podcasts rather than Wall Street ones, so treat this as a read on what carriers are actually doing on the ground, not on how the sell-side is positioning.
TL;DR
- UnitedHealth's (UNH) 2027 reset is now visible. It is dropping PPOs, doubling down on HMOs and special-needs plans, and says it has been winning back members every month since losing "nearly a million" a year ago, growing faster than any other carrier by July. Benefits on its core plans stay steady; the pain is being pushed onto PPO holders and drug copays.
- A new lever to cut off bad enrollment. Medicare's regulator (CMS) now lets carriers write hard enrollment caps directly into their 2027 plan bids. Once a plan hits its number, it closes to everyone. That is a cleaner way to stop unprofitable growth than the "hide the plan / stop paying agents" tricks carriers have leaned on for two years.
- Two negative data points. Humana-owned Village Health agreed to a $542 million settlement for overbilling Medicare (the podcast said codes were added without seeing patients), a fresh, dollar-sized reminder that the coding and audit risk is real. And employers keep dropping weight-loss drug (GLP-1) coverage, with PepsiCo joining Starbucks.
What's new
1. UnitedHealth's 2027 plan: fewer PPOs, steadier HMOs, win the members back. The clearest window into 2027 came from The Broker Link, an insurance-agent podcast (2026-09-01) that walked through UnitedHealth's (UNH) national sales kickoff. The hosts are field distributors relaying a presentation by a UHC sales leader they name as "Rachel." The substance: UHC "lost nearly a million members" during last year's enrollment season, then "started steadily winning them back… more and more every month until July, they grew more than any other carrier." For 2027 the company is "prioritizing HMOs… moving away from PPOs, going all in on HMOs with a renewed focus on D-SNPs, C-SNPs, and MedSup" (these are tightly managed plans and plans for low-income or chronically ill members). It is keeping HMO benefits "very steady," while the cuts land elsewhere: many PPO plans were made "non-commissionable" (agents are not paid to sell them, a signal the carrier wants that book gone), and Tier-3 drugs are moving "from copay to coinsurance, being subject to the deductible."
Why it matters: This is the "shrink to fix" thesis playing out in real benefit design. UNH is deliberately shedding its worst risk (PPOs) and protecting its profitable HMO core rather than buying growth. Two numbers the hosts flagged are margin-relevant: "86% of the market will still have access to zero-premium plans" (so the $0-premium fight continues), and "95% of members did not hit the MOOP," the maximum out-of-pocket cap, which the hosts read as room to raise that cap and hold everything else steady. They also noted hospital readmissions are now 9% of Star-rating measures, up from 1% "just a few years ago," with a two-year lag, which is why UHC is leaning on Optum home-care teams post-discharge to keep members out of the ER.
2. Regulators give carriers a new "closed means closed" enrollment cap. The Seven Figures Or Bust Podcast! (2026-08-31), hosted by a Medicare insurance agency, broke down a change from CMS that lets Medicare Advantage carriers build hard enrollment caps into their 2027 bids, approved up front, before the enrollment season. Previously a cap could only be done case-by-case ("backdoor"); now it is a front-door tool. The host's key point: "closed means closed." Once a plan hits its cap, it shuts to every channel (agents, the carrier's own call centers, Medicare.gov), and applications are processed by timestamp until the limit is hit.
Why it matters: This is a cleaner, more surgical way for carriers to stop unprofitable enrollment than the two blunt tools they have used for two years: hiding plans from quote engines ("suppression") and cutting agent commissions ("non-commissionable"). For investors it reinforces the discipline story, since carriers can now precisely throttle growth into 2027 instead of taking in more members than they can price. The catch, the host stressed, is that CMS has not disclosed which carriers or plans are using it, so we will not know the scale until plans actually start capping.
3. Humana's coding problem gets a price tag: $542 million. On Health:Further (2026-08-29), the hosts, healthcare-industry commentators, flagged that "Humana-owned Village Health agrees to a $542 million settlement for overbilling Medicare." Their characterization of the conduct was blunt: this was "far worse" than the usual complaint about home visits that find new diagnoses, because "they inserted additional diagnosis codes without seeing the patient… sometimes years after the patient's actual visit… much, much closer to fraud." This is the podcast's account, so treat the specific dollar figure and framing as their reporting.
Why it matters: Risk-adjustment coding, how carriers get paid more for sicker members, is the exact pressure point behind the V28 payment overhaul, RADV audits, and the long-running DOJ probe into UnitedHealth. A settled dollar figure attached to a Humana (HUM) asset is a concrete reminder that this liability is not theoretical and can surface in acquired businesses. The same episode noted academic hospital system UPMC "swings to an $18.3 million operating loss in Q2," a reminder that providers are still squeezed.
4. Employers keep walking away from weight-loss drug coverage. Two podcasts converged on the same theme: the people paying for GLP-1 weight-loss drugs (Wegovy, Zepbound) are backing out. On On The Pen GLP-1 News (2026-09-02), the hosts noted PepsiCo followed Starbucks in dropping obesity-drug coverage, telling employees GLP-1s "have essentially become one of the fastest growing expenses in their health care plan," and warned of "a large-scale pullback in employer-sponsored plans." On Becker's Healthcare Podcast (2026-09-02), health-policy expert Dr. Ezekiel Emanuel and industry expert Miriam Paramore discussed how "Cigna or Aetna recently said they're no longer covering it for their employees," the logic being that direct-to-consumer cash prices have fallen so far it no longer makes sense to run it through insurance: "when the insurance company is getting charged $1,000 a month and premiums are $1,000… the numbers don't work." They cited 31 million people now on GLP-1s, with cash prices "cut in half, if not by more" versus the old ~$1,000/month, and compounded versions "90% cheaper."
Why it matters: Every dollar of GLP-1 spend that shifts from insurers and employers to cash pay is a dollar off the medical-cost trend that has been crushing managed-care margins. It is a genuine, if slow, pressure valve. The offset (from On The Pen): a temporary Medicare Part D "bridge" program for obesity drugs has already signed up more than 600,000 people at $50/month since July 1, running through the end of 2027, so Medicare is quietly taking on some of the cost employers are shedding.
5. The $1 trillion Medicaid cut starts to bite, bad for the safety-net insurers. Healthy Dialogue (2026-09-03), hosted by health-policy academics, laid out the Medicaid cuts in the "One Big Beautiful Bill Act" (OBBBA, signed 2025-07-04): "nearly a trillion-dollar reduction in federal spending… about a 15% annual reduction in the federal commitment to Medicaid" over ten years, with an estimated 7.5 million people losing coverage. The mechanism is administrative: new work and community-engagement requirements (at least 80 hours a month, re-proven with paperwork every six months) that cause "procedural" disenrollments even among people who qualify. They cited RAND estimates that West Virginia sees the biggest hit, roughly a 20% coverage loss, and a KFF poll showing 63% view the law unfavorably.
Why it matters: This is the core risk for the Medicaid-heavy insurers (CNC, MOH, and the Medicaid books at ELV and UNH). Fewer, sicker members left in the pool ("acuity shift") plus states squeezed on funding is the exact setup that pressures Medicaid margins into 2027.
The debate
Bull case: the trough is behind us, and 2027 is where it gets fixed. The 2027 designs leaking this week are what a disciplined reset looks like: UNH holding HMO benefits steady while cutting loose PPOs, monetizing drug copays, and using new tools (enrollment caps) to refuse unprofitable growth. Utilization pressure has an escape hatch as GLP-1 costs move to cash pay and off insurer books. If carriers can hold or improve margins in 2027 without another round of member losses, the earnings power that the market has written off comes back, and these stocks re-rate off depressed multiples.
Bear case: this is a multi-year grind, not a one-year dip. Look at what the "fix" actually requires. UNH is willing to shed a million members and walk away from an entire product line (PPOs) to protect margin. That is not a business firing on all cylinders, it is triage. The coding and audit liability is live and now carries settled dollar figures (Humana and Village Health, $542M). Medicaid is losing ~7.5 million members and a trillion dollars of federal money, which hollows out CNC and MOH. And the political backdrop is openly hostile: the week's coverage was thick with "insurers deny care / profit motive" framing. Margins may improve, but on a smaller, more heavily scrutinized, lower-multiple business.
Where the week tilts: toward "reset is on track but slow." The 2027 designs confirm carriers are doing the disciplined thing; they do not yet confirm carriers can grow again. The number that settles the debate, whether anyone holds margin in 2027 without shrinking further, is still a few weeks away.
Stocks in play
No sell-side or buy-side podcast issued a ticker-level call on the managed-care names this week. The one hedge-fund podcast in the set, Hedge Fund Tips with Tom Hayes (2026-09-02), talked up Stanley Black & Decker (SWK), Tesla (TSLA), Pfizer (PFE), Dentsply Sirona (XRAY) and Treasuries, and said nothing about health insurers. The stances below combine this week's real developments with the standing setup; only the UNH points are backed by fresh podcast detail.
| Ticker | Bull | Bear | Next catalyst / number to watch |
|---|---|---|---|
| UNH | Executing the cleanest reset: dropping PPOs, steady HMO benefits, winning members back monthly, Optum home-care lowering readmissions | Coding and DOJ risk is live (Humana settlement is a read-across); "winning back" is still recovering ground it lost | Do 2027 bids hold margin without another leg of member loss; DOJ MA-coding probe |
| CVS | Aetna GLP-1 discipline (dropping employer coverage where cash is cheaper) protects trend | PBM (Caremark) sits squarely in the drug-pricing crosshairs raised on Becker's | 2027 benefit design; whether Aetna follows UNH's PPO retreat |
| HUM | Furthest along "shrink to fix," most transparent about the reset | $542M Village Health Medicare overbilling settlement is a fresh, dollar-sized coding hit | Can 2027 bids stop the membership shrink; any more audit or coding surprises |
| ELV | Diversified across MA, Medicaid and exchanges | Medicaid book directly exposed to the OBBBA coverage losses and acuity shift | 2027 Medicaid rate adequacy vs. a sicker remaining pool |
| CNC | Most disciplined Medicaid underwriter; aggressive on exiting bad states | Most exposed to the ~7.5M Medicaid coverage loss and paperwork-driven disenrollment | State Medicaid rate updates vs. acuity; exchange-subsidy outcome |
| MOH | Focused, disciplined Medicaid specialist | Most levered of all to Medicaid disenrollment and the acuity shift | State rate adequacy as the pool gets sicker and smaller |
| CI | Cleanest of the group: little MA exposure, Evernorth growing | Express Scripts (PBM) is the standing target of the drug-pricing reform push | PBM legislation; whether GLP-1 cash-pay shift dents Express Scripts volume |
Read-throughs
- Medicaid insurers (CNC, MOH; Medicaid books at ELV, UNH): The Healthy Dialogue breakdown of the ~$1 trillion, ~15%-a-year federal Medicaid cut and ~7.5 million coverage loss is the single biggest structural overhang for this group. The damage is not just fewer members, it is a sicker leftover pool ("acuity shift") plus states forced to trim provider payments and optional benefits. Watch state-by-state rate negotiations into 2027.
- PBMs and Optum-style service arms (Caremark/CVS, Express Scripts/CI, Optum Rx/UNH): The Becker's episode is the clearest statement of the direction of travel: drug pricing moving direct-to-consumer, "pay on net" rules, and open calls for federal price regulation on branded drugs. Near-term this compresses the old rebate-driven PBM economics; the offset is that GLP-1 volume leaving insurance lowers the medical-cost trend. On the services side, UHC's post-discharge Optum home-care model was cited as its main tool to cut readmissions (now 9% of Star scores).
- Hospitals and providers: The other side of the utilization trade is under pressure too. UPMC's $18.3 million Q2 operating loss (Health:Further), plus the warning on Healthy Dialogue that Medicaid cuts "could result in hospital closures," especially rural hospitals with thin margins and high Medicaid mixes. Providers absorbing more uninsured ER visits is a cost that eventually loops back to the system.
- GLP-1 cost exposure: The clearest positive for insurer trend this week. Employers (PepsiCo, Starbucks) and at least one large carrier (Cigna or Aetna, per Becker's) are pushing GLP-1s off their books toward cash pay, where prices have fallen by half to two-thirds. The Medicare Part D bridge (600,000+ enrollees at $50/month, temporary through end-2027) shifts some of that cost to the government, not the carriers. New cardiovascular data behind an FDA indication granted this week strengthens the long-term case for coverage, a future cost pressure rather than a this-year one.
What changed vs last week
This week delivered real, investable detail:
- New this week: UNH's 2027 benefit-design direction (drop PPOs, steady HMOs, win-backs); the new CMS front-door enrollment-cap tool; the $542M Humana and Village Health Medicare overbilling settlement; PepsiCo joining Starbucks in dropping GLP-1 coverage and a carrier (Cigna or Aetna) doing the same; and a thorough walk-through of the OBBBA Medicaid cuts.
- Medigap Plan G premium acceleration, the one signal carried over from the prior week, was not advanced by any podcast this week.
- Watch list for next week: any sell-side or buy-side ticker-level stance on the group; a UNH DOJ MA-coding update; RADV audit specifics; Star-ratings litigation; ACA exchange enhanced-subsidy expiration detail and 2027 rate filings; and M&A chatter (Optum carveout, CVS strategic review, Humana Medicaid sale). The 2027 story is opening up on the benefit-design side but is still quiet on how the Street is positioning around it.
Next catalyst: the rest of the 2027 "first look" benefit designs rolling out now through late September, specifically, evidence that any carrier can hold margin in 2027 without another round of membership cuts.